Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.

Journal of hepatology - 1 Feb 2006

Cornberg Markus, Hadem Johannes, Herrmann Eva, Schuppert Frank, Schmidt Hartmut H-J, Reiser Markus, Marschal Oliver, Steffen Martin, Manns Michael P, Wedemeyer Heiner

Abstract excerpt

BACKGROUND/AIMS: Therapeutic options for hepatitis C non-responder patients are limited. METHODS: We initiated an open-label pilot study to investigate the efficacy of CIFN plus ribavirin on viral kinetics, sustained virological response (SVR), and histological response in hepatitis C non-responder patients. Seventy-seven patients were enrolled to receive CIFN given daily in combination with 1000/1200 mg...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiviral Agents
Share to Drug Administration Schedule

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Drug Therapy, Combination

Share to Hepacivirus

Share to Hepatitis C, Chronic

Share to Interferons

Share to Pilot Projects

Share to Ribavirin

Source

Identifiers

PMID: 16360972
DOI: 10.1016/j.jhep.2005.10.021

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Treatment with daily consensus interferon (CIFN) plus ribavirin in non-responder patients with chronic hepatitis C: a randomized open-label pilot study.PMID 16360972Read ↗

Recent i.v.-drug users with chronic hepatitis C can be efficiently treated with daily high dose induction therapy using consensus interferon: an open-label pilot study.Semantic proximity Read ↗

Treatment of chronic hepatitis C with consensus interferon: a multicenter, randomized, controlled trial. Consensus Interferon Study Group.Semantic proximity Read ↗

Response guided therapy in patients with chronic hepatitis C - yesterday, today and tomorrow.Semantic proximity Read ↗

Interferon retreatment in chronic hepatitis C: which patients to choose, and what schedule to use.Semantic proximity Read ↗

A randomized trial of consensus interferon in combination with ribavirin as initial treatment for chronic hepatitis C.Semantic proximity Read ↗

Non-responders to previous treatment for hepatitis C.Semantic proximity Read ↗

Response-guided therapy in patients with genotype 1 hepatitis C virus: current status and future prospects.Semantic proximity Read ↗

Peginterferon alfa-2b plus ribavirin for naïve patients with genotype 1 chronic hepatitis C: a randomized controlled trial.Semantic proximity Read ↗

Ultrarapid hepatitis C virus clearance by daily high-dose interferon in non-responders to standard therapy.Semantic proximity Read ↗

Treatment options for nonresponders and relapsers to initial therapy for hepatitis C.Semantic proximity Read ↗

Daily interferon monotherapy for chronic hepatitis C in patients with normal or near-normal serum alanine transaminase levels: a comparison of two protocols.Semantic proximity Read ↗

Re-treatment with highly purified nIFNα in Mexican nonresponder patients with chronic genotype 1 hepatitis C.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.